Searched for
XARELTO
Bayer's Asundexian drug reduces stroke risk by 26% in studyAsundexian reduced the chance of another stroke by 26% compared with placebo, when added to standard antiplatelet therapy such as Aspirin, ...- Stop now - 4 medications you should never take with Omega-3 supplements, experts warnOmega-3 supplements are famous for their advantages to heart, brain, and overall health. “Omega-3s are essential fats that act like multita...
- Pharma companies set for strong performance in March 2025 quarter amid earning weaknessSun Pharma is expected to post a 9% year-on-year revenue growth, supported by its US specialty portfolio and steady growth in chronic thera...
- Stocks in news: ICICI Lombard, ICICI Pru Life, IREDA, Dr Reddy's, GAILDr Reddy's has denied the workforce reduction claims. "We categorically deny the claim of a 25% workforce cost reduction and the other clai...
- Lupin shares rise nearly 3% on launch of Rivaroxaban Tablets USP, in the USLupin's shares increased by 21.51% over the past year. However, year-to-date (YTD), the stock has decreased by 14.21%. Over the last six mo...
- White House says deals struck to cut prices of popular Medicare drugs that cost $50 billion yearlyThe Biden administration announced agreements with drug companies to lower the cost of 10 major Medicare medications, potentially saving ta...
- US names first 10 drugs for Medicare price negotiationThe Biden administration has released a list of 10 prescription medicines that will be subject to price negotiations by the U.S. Medicare h...
- Bayer steps up India R&D, clinical trials"Our strategy for India in pharmaceuticals is to continue to make significant investments, we believe that India is a growing market with a...
- Cadila, Bayer extend JV partnership for three years"The spirit of partnership in this joint venture has all been about channelling the core strengths of both Zydus and Bayer for the benefit ...
- Natco Pharma launches anti blood clot medication, Rivaroxaban, in IndiaRivaroxaban is an anticoagulant medication used to treat and prevent blood clots. The medication is currently sold by Bayer under the brand...
- Alembic Pharma gets tentative USFDA nod for generic Rivaroxaban tabletsRivaroxaban tablets are indicated for multiple conditions, including reduction of risk of stroke and systemic embolism in patients with non...
- Bayer Pharmaceuticals committed to India growth; to push for more R&D"Asia Pacific is the fastest growing region for Bayer's pharmaceuticals sales globally. We are very interested and committed to India and a...
- Indian drug makers can export patented meds for approval: Delhi High CourtNatco and Alembic, however, were directed to undertake that during the life of the respective patent, they will not export the respective p...
- Delhi High Court favours Natco, Alembic; allows them to export generics of Bayer's drugsBayer had approached court in 2016 to stop Alembic Pharmaceuticals from exporting its generic of the German company's blood thinner brand '...
- Delhi HC turns down Bayer plea on stroke drug against Dr Reddy'sIn India, Bayer sells the product through its equal stake JV Bayer Zydus, formed with Ahmedabad-based Zydus Cadila.
- Johnson & Johnson to buy back shares up to $10 billionThe company said on Tuesday it had about 2.77 billion shares of common stock outstanding as of Sept. 27.
- Zydus to invest Rs 100 crore in Vadodara unit, expand hospital businessZydus Hospitals & Healthcare Research recently started its first hospital operations at Anand, better known as Amul's hometown.
Load More
